NASDAQ:AKTX

Akari Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy AKTX

*Your capital is at risk

$14.99

+0.355 (+2.43%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

AKTX Prediction Chart

AKTX Predictions History

Latest community submissions for AKTX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
JS Pro	Mar 20, 2019	$4.42 -99.87%	$4.10	V	92.20%
Daryll @Daryll.104144	Mar 15, 2019	$5.47 -99.83%	$4.08	V	65.90%
JS Pro	Mar 15, 2019	$5.47 -99.83%	$4.08	V	65.90%
JS Pro	Mar 14, 2019	$5.48 -99.88%	$5.80	V	94.50%
Gp Merchant @Gp.98898	Mar 14, 2019	$3.65 -99.92%	$5.80	V	62.90%
JS Pro	Apr 3, 2017	$10.75 -99.89%	$11.71	V	91.80%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for AKTX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT AKARI THERAPEUTICS PLC

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by